Liver X Receptor Mediates Hepatic Triglyceride Accumulation Through Upregulation of G0/G1 Switch Gene 2 Expression
Overview
General Medicine
Authors
Affiliations
Liver X receptors (LXRs) are transcription factors essential for cholesterol homeostasis and lipogenesis. LXRα has been implicated in regulating hepatic triglyceride (TG) accumulation upon both influx of adipose-derived fatty acids (FAs) during fasting and stimulation of de novo FA synthesis by chemical agonism of LXR. However, whether or not a convergent mechanism is employed to drive deposition of FAs from these 2 different sources in TGs is undetermined. Here, we report that the G0/G1 Switch Gene 2 (G0S2), a selective inhibitor of intracellular TG hydrolysis/lipolysis, is a direct target gene of LXRα. Transcriptional activation is conferred by LXRα binding to a direct repeat 4 (DR4) motif in the G0S2 promoter. While LXRα mice exhibited decreased hepatic G0S2 expression, adenoviral expression of G0S2 was sufficient to restore fasting-induced TG storage and glycogen depletion in the liver of these mice. In response to LXR agonist T0901317, G0S2 ablation prevented hepatic steatosis and hypertriglyceridemia without affecting the beneficial effects on HDL. Thus, the LXRα-G0S2 axis plays a distinct role in regulating hepatic TG during both fasting and pharmacological activation of LXR.
Korenfeld N, Gorbonos T, Romero Florian M, Rotaro D, Goldberg D, Radushkevitz-Frishman T PLoS Biol. 2024; 22(9):e3002735.
PMID: 39241209 PMC: 11379474. DOI: 10.1371/journal.pbio.3002735.
Johnson S, Bao H, McMahon C, Chen Y, Burr S, Anderson A Nat Commun. 2024; 15(1):4847.
PMID: 38844467 PMC: 11156938. DOI: 10.1038/s41467-024-49224-x.
Li Z, Hales B, Robaire B Endocrinology. 2024; 165(4).
PMID: 38376928 PMC: 10914377. DOI: 10.1210/endocr/bqae024.
Opryshko V, Prokhach A, Akimov O, Riabushko M, Kostenko H, Kostenko V Heliyon. 2024; 10(3):e25058.
PMID: 38317880 PMC: 10838797. DOI: 10.1016/j.heliyon.2024.e25058.
Bile Acids Induce Neurite Outgrowth in Nsc-34 Cells via TGR5 and a Distinct Transcriptional Profile.
Ackerman H, Gerhard G Pharmaceuticals (Basel). 2023; 16(2).
PMID: 37259326 PMC: 9963315. DOI: 10.3390/ph16020174.